Estimating future hepatitis C morbidity, mortality, and costs in the United States
- PMID: 11029989
- PMCID: PMC1446368
- DOI: 10.2105/ajph.90.10.1562
Estimating future hepatitis C morbidity, mortality, and costs in the United States
Abstract
Objectives: This study estimated future morbidity, mortality, and costs resulting from hepatitis C virus (HCV).
Methods: We used a computer cohort simulation of the natural history of HCV in the US population.
Results: From the year 2010 through 2019, our model projected 165,900 deaths from chronic liver disease, 27,200 deaths from hepatocellular carcinoma, and $10.7 billion in direct medical expenditures for HCV. During this period, HCV may lead to 720,700 years of decompensated cirrhosis and hepatocellular carcinoma and to the loss of 1.83 million years of life in those younger than 65 at a societal cost of $21.3 and $54.2 billion, respectively. In sensitivity analysis, these estimates depended on (1) whether patients with HCV and normal transaminase levels develop progressive liver disease, (2) the extent of alcohol ingestion, and (3) the likelihood of dying from other causes related to the route of HCV acquisition.
Conclusions: Our results confirm prior Centers for Disease Control and Prevention projections and suggest that HCV may lead to a substantial health and economic burden over the next 10 to 20 years.
Similar articles
-
Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.J Viral Hepat. 2009 Sep;16(9):650-8. doi: 10.1111/j.1365-2893.2009.01115.x. Epub 2009 Apr 20. J Viral Hepat. 2009. PMID: 19413698
-
Simulation of hepatitis C based on a mandatory reporting system.Eur J Gastroenterol Hepatol. 2002 Jan;14(1):25-34. doi: 10.1097/00042737-200201000-00006. Eur J Gastroenterol Hepatol. 2002. PMID: 11782572
-
Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.J Viral Hepat. 2017 Nov;24(11):955-965. doi: 10.1111/jvh.12728. Epub 2017 Aug 16. J Viral Hepat. 2017. PMID: 28815822 Free PMC article.
-
Hepatocellular carcinoma and hepatitis C in the United States.Hepatology. 2002 Nov;36(5 Suppl 1):S74-83. doi: 10.1053/jhep.2002.36807. Hepatology. 2002. PMID: 12407579 Review.
-
Understanding hepatitis C.Am J Manag Care. 2004 Mar;10(2 Suppl):S21-9. Am J Manag Care. 2004. PMID: 15084064 Review.
Cited by
-
Increasing hepatitis C prevalence and associated risk behaviors among incarcerated young adults.J Urban Health. 2014 Apr;91(2):376-82. doi: 10.1007/s11524-013-9807-x. J Urban Health. 2014. PMID: 23722268 Free PMC article.
-
Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution.J Virol. 2007 Jun;81(12):6513-22. doi: 10.1128/JVI.02276-06. Epub 2007 Feb 28. J Virol. 2007. PMID: 17329332 Free PMC article.
-
Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link.Cancer. 2009 Dec 15;115(24):5651-61. doi: 10.1002/cncr.24687. Cancer. 2009. PMID: 19834957 Free PMC article. Review.
-
Protein-protein interactions of human viruses.Semin Cell Dev Biol. 2020 Mar;99:31-39. doi: 10.1016/j.semcdb.2018.07.018. Epub 2018 Jul 26. Semin Cell Dev Biol. 2020. PMID: 30031213 Free PMC article. Review.
-
Risk factors for hepatitis C virus infection among homeless adults.J Gen Intern Med. 2002 Feb;17(2):134-43. doi: 10.1046/j.1525-1497.2002.10415.x. J Gen Intern Med. 2002. PMID: 11841529 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical